I am glad to be part of a multi-institutional team newly commissioned to analyze the security of biomanufacturing infrastructures.
Facilities that manufacture biologic drugs like vaccines are a critical part of the nation’s biodefense infrastructure. Possible breaches of data systems controlling these biomanufacturing supply chains call for an assessment of their vulnerability to cyberattacks.
The U.S. Department of Defense has awarded a contract to the National Strategic Research Institute (NSRI) at the University of Nebraska to lead the research project in cyberbiosecurity, engaging a team of scientists that includes Peccoud, along with researchers at the University of Nebraska-Lincoln, Virginia Tech and U.S. Strategic Command. Their aim is to provide specific recommendations to the Department of Defense for strengthening biomanufacturing infrastructure.
The Biological Process Development Facility at University of Nebraska-Lincoln will serve as the proof-of-concept centerpiece facility for the project led by Randall Murch, associate director for research program development at Virginia Tech.
The complete press-release is at from the CSU web site.